• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjects

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    SIOP Ependymoma I: Final results, long term follow-up and molecular analysis of the trial cohort: A BIOMECA Consortium Study

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    Ritzman.pdf
    Size:
    1.497Mb
    Format:
    PDF
    Description:
    From UNPAYWALL
    Download
    Authors
    Ritzmann, T. A.
    Chapman, R. J.
    Kilday, J. P.
    Thorp, N.
    Modena, P.
    Dineen, R. A.
    Macarthur, D.
    Mallucci, C.
    Jaspan, T.
    Pajtler, K. W.
    Giagnacovo, M.
    Jacques, T. S.
    Paine, S. M. L.
    Ellison, D. W.
    Bouffet, E.
    Grundy, R. G.
    Show allShow less
    Affiliation
    Children's Brain Tumour Research Centre, University of Nottingham, UK. Nottingham University Hospitals NHS Trust, UK. Children's Brain Tumour Research Network (CBTRN), Royal Manchester Children's Hospital, UK. The Centre for Paediatric, Teenage and Young Adult Cancer, University of Manchester, UK. The Clatterbridge Cancer Centre, Liverpool, UK. The Christie Hospital Proton Beam Therapy Centre, Manchester, UK. Genetics Unit, ASST Lariana General Hospital, Italy. NIHR Nottingham Biomedical Research Centre. Alder Hey Children's NHS Foundation Trust. Hopp Children's Cancer Center Heidelberg (KiTZ), Germany. Division of Pediatric Neuro-oncology, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Germany. Department of Pediatric Oncology, Hematology, and Immunology, University Hospital Heidelberg, Germany. UCL GOS Institute of Child Health, London, UK. Great Ormond Street Hospital for Children NHS Foundation Trust, UK. Department of Pathology, St. Jude Children's Research Hospital, USA. The Hospital for Sick Children, Toronto, Canada.
    Issue Date
    2022
    
    Metadata
    Show full item record
    Abstract
    Background SIOP Ependymoma I was a non-randomised trial assessing event free and overall survival (EFS/OS) of non-metastatic intracranial ependymoma in children aged 3–21 years treated with a staged management strategy. A further aim was to assess the response rate (RR) of subtotally resected (STR) ependymoma to vincristine, etoposide, and cyclophosphamide (VEC). We report final results with 12-year follow-up and post hoc analyses of recently described biomarkers. Methods Seventy-four participants were eligible. Children with gross total resection (GTR) received radiotherapy, whilst those with STR received VEC before radiotherapy. DNA methylation, 1q, hTERT, ReLA, Tenascin-C, H3K27me3, and pAKT status were evaluated. Results Five- and ten-year EFS was 49.5% and 46.7%, OS was 69.3% and 60.5%. GTR was achieved in 33/74 (44.6%) and associated with improved EFS (P = .003, HR = 2.6, 95% confidence interval (CI) 1.4–5.1). Grade 3 tumours were associated with worse OS (P = .005, HR = 2.8, 95%CI 1.3–5.8). 1q gain and hTERT expression were associated with poorer EFS (P = .003, HR = 2.70, 95%CI 1.49–6.10 and P = .014, HR = 5.8, 95%CI 1.2–28) and H3K27me3 loss with worse OS (P = .003, HR = 4.6, 95%CI 1.5–13.2). Methylation profiles showed expected patterns. 12 participants with STR did not receive chemotherapy; a protocol violation. However, best chemotherapy RR was 65.5% (19/29, 95%CI 45.7–82.1), exceeding the prespecified 45%. Conclusions Participants with totally resected ependymoma had the best outcomes. RR of STR to VEC exceeded the pre-specified efficacy criterion. However, cases of inaccurate stratification highlighted the need for rapid central review. 1q gain, H3K27me3 loss, and hTERT expression were all associated with poorer survival outcomes.
    Citation
    Ritzmann TA, Chapman RJ, Kilday J-P, Thorp N, Modena P, Dineen RA, et al. SIOP Ependymoma I: Final results, long-term follow-up, and molecular analysis of the trial cohort—A BIOMECA Consortium Study. Neuro-Oncology. Oxford University Press (OUP); 2022.
    Journal
    Neuro Oncol
    URI
    http://hdl.handle.net/10541/625081
    DOI
    10.1093/neuonc/noac012
    PubMed ID
    35018471
    Additional Links
    https://dx.doi.org/10.1093/neuonc/noac012
    Type
    Article
    Language
    en
    ae974a485f413a2113503eed53cd6c53
    10.1093/neuonc/noac012
    Scopus Count
    Collections
    All Christie Publications

    entitlement

    Related articles

    • Conformal Radiation Therapy for Pediatric Ependymoma, Chemotherapy for Incompletely Resected Ependymoma, and Observation for Completely Resected, Supratentorial Ependymoma.
    • Authors: Merchant TE, Bendel AE, Sabin ND, Burger PC, Shaw DW, Chang E, Wu S, Zhou T, Eisenstat DD, Foreman NK, Fuller CE, Anderson ET, Hukin J, Lau CC, Pollack IF, Laningham FH, Lustig RH, Armstrong FD, Handler MH, Williams-Hughes C, Kessel S, Kocak M, Ellison DW, Ramaswamy V
    • Issue date: 2019 Apr 20
    • Final results of the second prospective AIEOP protocol for pediatric intracranial ependymoma.
    • Authors: Massimino M, Miceli R, Giangaspero F, Boschetti L, Modena P, Antonelli M, Ferroli P, Bertin D, Pecori E, Valentini L, Biassoni V, Garrè ML, Schiavello E, Sardi I, Cama A, Viscardi E, Scarzello G, Scoccianti S, Mascarin M, Quaglietta L, Cinalli G, Diletto B, Genitori L, Peretta P, Mussano A, Buccoliero A, Calareso G, Barra S, Mastronuzzi A, Giussani C, Marras CE, Balter R, Bertolini P, Giombelli E, La Spina M, Buttarelli FR, Pollo B, Gandola L
    • Issue date: 2016 Oct
    • Treatment and outcome of pediatric intracranial ependymoma after first relapse.
    • Authors: Liu ZM, Han Z, Wang JM, Sun T, Liu W, Li B, Gong J, Li CD, Zhao F, Tian YJ
    • Issue date: 2022 May
    • Copy number gain of 1q25 predicts poor progression-free survival for pediatric intracranial ependymomas and enables patient risk stratification: a prospective European clinical trial cohort analysis on behalf of the Children's Cancer Leukaemia Group (CCLG), Societe Francaise d'Oncologie Pediatrique (SFOP), and International Society for Pediatric Oncology (SIOP).
    • Authors: Kilday JP, Mitra B, Domerg C, Ward J, Andreiuolo F, Osteso-Ibanez T, Mauguen A, Varlet P, Le Deley MC, Lowe J, Ellison DW, Gilbertson RJ, Coyle B, Grill J, Grundy RG
    • Issue date: 2012 Apr 1
    • Outcomes following myxopapillary ependymoma resection: the importance of capsule integrity.
    • Authors: Abdulaziz M, Mallory GW, Bydon M, De la Garza Ramos R, Ellis JA, Laack NN, Marsh WR, Krauss WE, Jallo G, Gokaslan ZL, Clarke MJ
    • Issue date: 2015 Aug
    DSpace software (copyright © 2002 - 2023)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.